S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48

Medtronic Stock Forecast, Price & News

+0.27 (+0.25%)
(As of 01/19/2022 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
7.28 million shs
Average Volume
5.67 million shs
Market Capitalization
$144.89 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive MDT News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.

Medtronic logo

About Medtronic

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consists of products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Minimally Invasive Technologies Group segment focuses on respiratory system, gastrointestinal tract, renal system, lungs, pelvic region, kidneys, and obesity diseases. The Restorative Therapies Group segment comprises of neurostimulation therapies and drug delivery systems for the treatment of chronic pain, as well as areas of the spine and brain, along with pelvic health and conditions of the ear, nose, and throat. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.


Medtronic (NYSE:MDT) PT Lowered to $129.00 at Citigroup
January 19, 2022 |  americanbankingnews.com
Medtronic (NYSE:MDT) Price Target Cut to $115.00
January 18, 2022 |  americanbankingnews.com
1 Green Flag for Medtronic in 2022, and 1 Red Flag
January 14, 2022 |  finance.yahoo.com
3 Reasons Medtronic Is A Buy - Seeking Alpha
January 11, 2022 |  seekingalpha.com
Medtronic (MDT) to Buy Affera, Expand in Electrophysiology
January 11, 2022 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Electromedical equipment
Health Care Equipment
Year Founded

Sales & Book Value

Annual Sales
$30.12 billion
Cash Flow
$4.71 per share
Book Value
$38.28 per share


Net Income
$3.61 billion
Pretax Margin




Outstanding Shares
Free Float
Market Cap
$144.89 billion

Company Calendar

Last Earnings
Ex-Dividend for 1/14 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Social Links


Overall MarketRank

3.41 out of 5 stars

Medical Sector

2nd out of 1,415 stocks

Electromedical Equipment Industry

1st out of 29 stocks

Analyst Opinion: 3.3Community Rank: 5.0Dividend Strength: 4.2Insider Behavior: 3.3Valuation: 1.3 5 -4 -3 -2 -1 -

Medtronic (NYSE:MDT) Frequently Asked Questions

Is Medtronic a buy right now?

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 9 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Medtronic stock.
View analyst ratings for Medtronic
or view top-rated stocks.

How has Medtronic's stock been impacted by COVID-19?

Medtronic's stock was trading at $92.44 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MDT shares have increased by 16.6% and is now trading at $107.76.
View which stocks have been most impacted by COVID-19

Are investors shorting Medtronic?

Medtronic saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 11,660,000 shares, an increase of 19.2% from the December 15th total of 9,780,000 shares. Based on an average daily volume of 6,620,000 shares, the short-interest ratio is currently 1.8 days. Approximately 0.9% of the shares of the company are sold short.
View Medtronic's Short Interest

When is Medtronic's next earnings date?

Medtronic is scheduled to release its next quarterly earnings announcement on Tuesday, February 22nd 2022.
View our earnings forecast for Medtronic

How were Medtronic's earnings last quarter?

Medtronic plc (NYSE:MDT) released its quarterly earnings results on Tuesday, November, 23rd. The medical technology company reported $1.32 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.29 by $0.03. The medical technology company earned $7.85 billion during the quarter, compared to the consensus estimate of $7.98 billion. Medtronic had a net margin of 14.80% and a trailing twelve-month return on equity of 14.52%. The company's revenue was up 3.2% on a year-over-year basis. During the same quarter last year, the firm posted $1.02 earnings per share.
View Medtronic's earnings history

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic announced a quarterly dividend on Friday, December 10th. Investors of record on Wednesday, December 22nd will be paid a dividend of $0.63 per share on Friday, January 14th. This represents a $2.52 annualized dividend and a dividend yield of 2.34%. The ex-dividend date of this dividend is Tuesday, December 21st.
View Medtronic's dividend history

Is Medtronic a good dividend stock?

Medtronic pays an annual dividend of $2.52 per share and currently has a dividend yield of 2.34%. Medtronic has been increasing its dividend for 45 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Medtronic is 72.62%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Medtronic will have a dividend payout ratio of 40.98% next year. This indicates that Medtronic will be able to sustain or increase its dividend.
View Medtronic's dividend history.

What guidance has Medtronic issued on next quarter's earnings?

Medtronic issued an update on its FY 2022 earnings guidance on Tuesday, December, 7th. The company provided earnings per share guidance of $5.650-$5.750 for the period, compared to the Thomson Reuters consensus estimate of $5.710. The company issued revenue guidance of -.

What price target have analysts set for MDT?

22 brokers have issued 1 year target prices for Medtronic's stock. Their forecasts range from $104.00 to $165.00. On average, they expect Medtronic's stock price to reach $132.71 in the next year. This suggests a possible upside of 23.2% from the stock's current price.
View analysts' price targets for Medtronic
or view top-rated stocks among Wall Street analysts.

Who are Medtronic's key executives?

Medtronic's management team includes the following people:
  • Geoffrey Straub Martha, Chairman & Chief Executive Officer
  • Gregory L. Smith, Executive VP-Global Operations & Supply Chain
  • Karen L. Parkhill, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
  • Richard E. Kuntz, Chief Medical & Scientific Officer, Senior VP
  • Laura Mauri, Chief Clinical & Regulatory Officer, Senior VP

What is Omar S. Ishrak's approval rating as Medtronic's CEO?

1,925 employees have rated Medtronic CEO Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among Medtronic's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), Home Depot (HD) and Walmart (WMT).

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Who are Medtronic's major shareholders?

Medtronic's stock is owned by many different institutional and retail investors. Top institutional investors include Coho Partners Ltd. (0.12%), M&G Investment Management Ltd. (0.09%), Gateway Investment Advisers LLC (0.03%), WestEnd Advisors LLC (0.03%), Crossmark Global Holdings Inc. (0.02%) and Dudley & Shanley Inc. (0.02%). Company insiders that own Medtronic stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Omar Ishrak, Richard H Anderson, Richard H Anderson, Robert John White and Sean Salmon.
View institutional ownership trends for Medtronic

Which institutional investors are selling Medtronic stock?

MDT stock was sold by a variety of institutional investors in the last quarter, including M&G Investment Management Ltd., Coho Partners Ltd., Stock Yards Bank & Trust Co., Ferguson Wellman Capital Management Inc., Chemung Canal Trust Co., Moody National Bank Trust Division, Confluence Investment Management LLC, and Gateway Investment Advisers LLC. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Brett A Wall, Geoffrey Martha, John R Liddicoat, Karen L Parkhill, Robert John White, and Sean Salmon.
View insider buying and selling activity for Medtronic
or view top insider-selling stocks.

Which institutional investors are buying Medtronic stock?

MDT stock was acquired by a variety of institutional investors in the last quarter, including Gradient Investments LLC, LVM Capital Management Ltd. MI, Cohen Klingenstein LLC, Professional Advisory Services Inc., Pendal Group Ltd, Aries Wealth Management, Edge Capital Group LLC, and Virginia Wealth Management Group Inc.. Company insiders that have bought Medtronic stock in the last two years include Omar Ishrak, and Richard H Anderson.
View insider buying and selling activity for Medtronic
or or view top insider-buying stocks.

How do I buy shares of Medtronic?

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $107.76.

How much money does Medtronic make?

Medtronic has a market capitalization of $144.89 billion and generates $30.12 billion in revenue each year. The medical technology company earns $3.61 billion in net income (profit) each year or $3.47 on an earnings per share basis.

How many employees does Medtronic have?

Medtronic employs 90,000 workers across the globe.

When was Medtronic founded?

Medtronic was founded in 1949.

What is Medtronic's official website?

The official website for Medtronic is www.medtronic.com.

Where are Medtronic's headquarters?

Medtronic is headquartered at 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at (531) 438-1700, via email at [email protected], or via fax at 763-514-4879.

This page was last updated on 1/20/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.